Catecholamine biosynthesis and secretion: physiological and pharmacological effects of secretin. 2011

Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
Department of Medicine, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0838, USA.

Pituitary adenylyl cyclase activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) augment the biosynthesis of tyrosine hydroxylase (TH). We tested whether secretin belonging to the glucagon/PACAP/VIP superfamily would increase transcription of the tyrosine hydroxylase (Th) gene and modulate catecholamine secretion. Secretin activated transcription of the endogenous Th gene and its transfected promoter (EC(50) ∼4.6 nM) in pheochromocytoma (PC12) cells. This was abolished by pre-treatment with a secretin receptor (SCTR) antagonist and by inhibition of protein kinase A (PKA), mitogen-activated protein kinase, or CREB (cAMP response element-binding protein). In agreement, secretin increased PKA activity and induced phosphorylation of CREB and binding to Th CRE, suggesting secretin signaling to transcription via a PKA-CREB pathway. Secretin stimulated catecholamine secretion (EC(50) ∼3.5 μM) from PC12 cells, but this was inhibited by pre-treatment with VIP-preferring receptor (VPAC1)/PACAP-preferring receptor (PAC1) antagonists. Secretin-evoked secretion occurred without extracellular Ca(2+) and was abolished by intracellular Ca(2+) chelation. Secretin augmented phospholipase C (PLC) activity and increased inositol-1,4,5-triphosphate (IP(3)) levels in PC12 cells; PLC-β inhibition blocked secretin-induced catecholamine secretion, indicating the participation of intracellular Ca(2+) from a phospholipase pathway in secretion. Like PACAP, secretin evoked long-lasting catecholamine secretion, even after only a transient exposure. Thus, transcription is triggered by nanomolar concentrations of the peptide through SCTR, with signaling along the cAMP-PKA and extracellular-signal-regulated kinase 1/2 pathways and through CREB. By contrast, secretion is triggered only by micromolar concentrations of peptide through PAC1/VPAC receptors and by utilizing a PLC/intracellular Ca(2+) pathway.

UI MeSH Term Description Entries
D010738 Type C Phospholipases A subclass of phospholipases that hydrolyze the phosphoester bond found in the third position of GLYCEROPHOSPHOLIPIDS. Although the singular term phospholipase C specifically refers to an enzyme that catalyzes the hydrolysis of PHOSPHATIDYLCHOLINE (EC 3.1.4.3), it is commonly used in the literature to refer to broad variety of enzymes that specifically catalyze the hydrolysis of PHOSPHATIDYLINOSITOLS. Lecithinase C,Phospholipase C,Phospholipases, Type C,Phospholipases C
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D004533 Egtazic Acid A chelating agent relatively more specific for calcium and less toxic than EDETIC ACID. EGTA,Ethylene Glycol Tetraacetic Acid,EGATA,Egtazic Acid Disodium Salt,Egtazic Acid Potassium Salt,Egtazic Acid Sodium Salt,Ethylene Glycol Bis(2-aminoethyl ether)tetraacetic Acid,Ethylenebis(oxyethylenenitrile)tetraacetic Acid,GEDTA,Glycoletherdiamine-N,N,N',N'-tetraacetic Acid,Magnesium-EGTA,Tetrasodium EGTA,Acid, Egtazic,EGTA, Tetrasodium,Magnesium EGTA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic

Related Publications

Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
August 1984, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
February 1981, Neuroendocrinology,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
January 2000, Acta physiologica Scandinavica,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
January 1963, Surgical forum,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
December 1962, Annals of surgery,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
February 1964, The American journal of digestive diseases,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
January 1979, Scandinavian journal of gastroenterology,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
December 1975, Canadian journal of physiology and pharmacology,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
December 1985, Journal de chirurgie,
Manjula Mahata, and Kuizing Zhang, and Jiaur R Gayen, and Suvobroto Nandi, and Bhawanjit K Brar, and Sajalendu Ghosh, and Nitish R Mahapatra, and Laurent Taupenot, and Daniel T O'Connor, and Sushil K Mahata
October 2002, FEBS letters,
Copied contents to your clipboard!